Genetic tests that came out positive-IGHV mutated Posts on Medivizor

Posted by Medivizor on Jun 30, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes for patients with chronic lymphocytic leukemia (CLL), with genetic abnormalities (mutated IGHV) and without del(17p)/TP53 mutation, who were treated with the iFCG (ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab) regimen.  This study concluded that this treatment regimen is...